GRI Bio
$2.29
48
+$0.03+1.33% Today
Statistics
Day High
2.29
Day Low
2.25
52W High
-
52W Low
-
Volume
92
Avg. Volume
-
Mkt Cap
3.31M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Dividends
0%Dividend Yield
Dec 19
$0.51
Sep 19
$0.27
Jun 19
$0.37
Mar 19
$0.35
Dec 18
$0.41
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
20MayExpected
Expected EPS
-3.74
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-23.91MNet Income
Analyst Ratings
$40.00Average Price Target
The highest estimate is 40.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow GRI.BOATS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap160.66B
Gilead Sciences
GILD
Mkt Cap148.78B
Biogen
BIIB
Mkt Cap22.63B
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Moderna
MRNA
Mkt Cap10.61B
Alnylam Pharmaceuticals
ALNY
Mkt Cap60.25B
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
Novartis
NVS
Mkt Cap237.61B
About
GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.
Show more...
CEO
Dr. W. Marc Hertz Ph.D.
Employees
3
Country
US
ISIN
US3622AW4030
Listings
0 Comments
Share your thoughts
FAQ
What is GRI Bio stock price today?▼
The current price of GRI.BOATS is $2.29 USD — it has increased by +1.33% in the past 24 hours. Watch GRI Bio stock price performance more closely on the chart.
What is GRI Bio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange GRI Bio stocks are traded under the ticker GRI.BOATS.
What is GRI Bio market cap?▼
Today GRI Bio has the market capitalization of 3.31M
When is the next GRI Bio earnings date?▼
GRI Bio is going to release the next earnings report on May 20, 2026.
What were GRI Bio earnings last quarter?▼
GRI.BOATS earnings for the last quarter are -13.25 USD per share, whereas the estimation was -29.26 USD resulting in a +54.72% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is GRI Bio revenue for the last year?▼
GRI Bio revenue for the last year amounts to 0 USD.
What is GRI Bio net income for the last year?▼
GRI.BOATS net income for the last year is -23.91M USD.
Does GRI Bio pay dividends?▼
Yes, GRI.BOATS dividends are paid quarterly. The last dividend per share was 0.51 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does GRI Bio have?▼
As of April 01, 2026, the company has 3 employees.
In which sector is GRI Bio located?▼
GRI Bio operates in the Health Care sector.
When did GRI Bio complete a stock split?▼
The last stock split for GRI Bio was on January 26, 2026 with a ratio of 1:28.
Where is GRI Bio headquartered?▼
GRI Bio is headquartered in La Jolla, US.